cached image

Patrick Cras, MD PhD

Affiliations: 
Neurology University of Antwerp, Antwerpen, Vlaanderen, Belgium 
Area:
dementia, Creutzfeldt-Jakob disease, cerebrospinal fluid, movement disorders and the neuropathology of neurodegenerative diseases
Website:
http://www.ua.ac.be/main.aspx?c=patrick.cras
Google:
"Patrick Cras"
Bio:

http://be.linkedin.com/pub/patrick-cras/11/b35/229
http://www.researchportal.be/en/person/patrick-cras-(UA_02429)/

Presently Chairman of the Department of Neurology of the University Hospital of Antwerp and professor of neurology at the University of Antwerp, Patrick Cras trained as a medical doctor at the University of Antwerp (UA, 1983), as an research fellow in the Laboratory of Neuropathology at the Born Bunge Institute (1983-1985), later in the laboratory of anatomopathology at the University Hospital Antwerp, after which he obtained a specialty certification in neurology (1989). This was followed by a Fogarty Fellowship at Case Western Reserve University, Cleveland Ohio (1989-1991), were he worked on a doctoral thesis on the Pathogenesis of senile plaques in Alzheimer’s disease. Appointed as an attending physician at the Dept. of Neurology at the University Hospital (1991), he became associate professor of neurology in 1995. He (co-)authored more than 160 international peer reviewed articles and received 3 research awards (Specia, Divry and Belgian Geriatric Society). He is also the Chairman of the Ethics committee, Antwerp University Hospital (2000-present) and University of Antwerp (2008-present), a member of several committees of the High Council for Medicine (Hoge Gezondheidsraad), the National Bioethics Committee (Raadgevend Comité voor Bioethiek), chairman of the Neurology Committee of the Commission for Accreditation of Medical Doctors, President of the Belgian Society of Neuropathology. After having served as a faculty based ombudsman since 1984, Patrick Cras is the central ombudsman of the University of Antwerp since 2004.

Patrick Cras’s Specialties:
His research interests involve dementia, Creutzfeldt-Jakob disease, cerebrospinal fluid, movement disorders and the neuropathology of neurodegenerative diseases. He is also interested in the ethics of human experimentation, end-of-life decisions and research involving vulnerable subjects.
(Show less)

Mean distance: 16.91 (cluster 28)
 
SNBCP
Cross-listing: Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mormont E, Bier JC, Bruffaerts R, et al. (2020) Practices and opinions about disclosure of the diagnosis of Alzheimer's disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementia. Acta Neurologica Belgica
Maréchal E, Denoiseux B, Thys E, et al. (2019) Impulsive-Compulsive Behaviours in Belgian-Flemish Parkinson's Disease Patients: A Questionnaire-Based Study. Parkinson's Disease. 2019: 7832487
Behaeghe O, Mangelschots E, De Vil B, et al. (2018) A systematic review comparing the diagnostic value of 14-3-3 protein in the cerebrospinal fluid, RT-QuIC and RT-QuIC on nasal brushing in sporadic Creutzfeldt-Jakob disease. Acta Neurologica Belgica. 118: 395-403
Baradaran-Heravi Y, Dillen L, Nguyen HP, et al. (2018) No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients. Neurobiology of Aging
Perrone F, Cacace R, Van Mossevelde S, et al. (2018) Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis. Neurobiology of Aging
De Roeck A, Duchateau L, Van Dongen J, et al. (2018) An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease. Acta Neuropathologica
Goossens J, Bjerke M, Van Mossevelde S, et al. (2018) Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimer's Research & Therapy. 10: 31
Willemse EAJ, Sieben A, Somers C, et al. (2018) P4-270: Neurogranin In Cerebrospinal Fluid Is Not Specific To Alzheimer'S Disease Dementia Alzheimers & Dementia. 14
Roeck AD, Duchateau L, Dongen JV, et al. (2018) O4-01-01: In-Depth Analysis Of An Abca7 Vntr In Alzheimer'S Disease Alzheimers & Dementia. 14
Goossens J, Bjerke M, Struyfs H, et al. (2017) No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis. Alzheimer's Research & Therapy. 9: 49
See more...